Dr. Mark A. McAllister, MD

Dr. McAllister practices at Retinal Consultants Medical Group in Sacramento, California.

Dr. McAllister's NPI, 1669934394, was assigned on April 2, 2019. Dr. McAllister graduated from McGovern Medical School in 2019. Dr. McAllister holds California license A196061.

Dr. McAllister's primary practice is Retinal Consultants Medical Group, at 3 Park Center Dr, Sacramento, CA 95825 in Sacramento County. The practice phone is (916) 596-2027.

Dr. McAllister's primary practice is Retinal Consultants Medical Group in Sacramento, California. Dr. McAllister is also affiliated with Dignity Health - Mercy General Hospital. The medical group on file is University of Illinois Physicians Group (UIPG). Dmand AI also links Dr. McAllister to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. McAllister practices, 2 sites in all. Vendor and product names are available with a free account.

Retina specialist is Dr. McAllister's primary specialty in the NPI Registry, under taxonomy code 207WX0107X. Dr. McAllister is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. McAllister's licenses on file in 2 states: California and Illinois.

CMS data shows 13 Medicare services from Dr. McAllister across 1 procedure code in 2024, for 41 Medicare patients. Medicare paid $217 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 41 Medicare patients who saw Dr. McAllister in 2024. The largest group is 65 to 74, with 14 patients. 66% of them have high blood pressure, and 56% have high cholesterol. 37% are also on Medicaid. Their average risk score is 0.95, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. McAllister's median patient age at 65, with 50% women.

In 2024, Dr. McAllister wrote 157 Medicare Part D claims for 73 patients. 69% of them were for generic drugs. CMS names the drug for 76 of them, across 4 drugs with 11 or more claims each, at $1,399 in total drug cost.

Dr. McAllister accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Cataract surgery: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 6 papers to Dr. McAllister, published from 2020 to 2025. 2022 was the busiest year, with 3. Dr. McAllister has published most often in J Vitreoretin Dis. Dr. McAllister's most frequent co-authors are Spencer Moore, MD, PhD, Brenna Bullock and Kenneth Chen Fan, MBA, MD.

CMS Open Payments shows 53 general payments to Dr. McAllister from 13 drug and device companies from 2020 to 2025. Food and beverage make up the largest share, 70% of the total. Alcon Laboratories Inc paid the most, $2,998. It also lists 7 research payments totaling $6,765 from 2024 to 2025.

Dr. McAllister graduated from McGovern Medical School in 2019.

Dr. McAllister is in network with 12 carriers, including Aetna, Elevance and HCSC. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.